| Preface |
|
ix | |
| Foreword |
|
x | |
|
|
|
1 | (37) |
|
1.1 Principles of neuroanatomy for diagnostic neuropathologists |
|
|
1 | (10) |
|
1.1.1 Anatomical orientation by using the ventricular system |
|
|
1 | (1) |
|
1.1.2 Major anatomical regions of interest |
|
|
2 | (5) |
|
1.1.3 Histological neuroanatomy |
|
|
7 | (4) |
|
1.2 Neuropathological techniques |
|
|
11 | (3) |
|
1.2.1 Necropsy techniques |
|
|
11 | (1) |
|
1.2.2 Brain sectioning, macroscopic inspection and sampling for histology |
|
|
12 | (2) |
|
1.3 Basic tissue reaction patterns |
|
|
14 | (14) |
|
1.3.1 Reactions of neurons to injury |
|
|
14 | (6) |
|
|
|
20 | (1) |
|
|
|
20 | (2) |
|
1.3.4 Microglia/macrophages |
|
|
22 | (1) |
|
|
|
23 | (1) |
|
|
|
23 | (1) |
|
1.3.7 Disturbance of water balance: edema |
|
|
24 | (2) |
|
1.3.8 Artifacts, postmortem degeneration, pseudolesions and old age |
|
|
26 | (2) |
|
1.4 Recognizing major lesion patterns |
|
|
28 | (5) |
|
1.4.1 The major lesion patterns |
|
|
28 | (3) |
|
1.4.2 Lesion distribution pattern |
|
|
31 | (1) |
|
1.4.3 Classification of neurological diseases |
|
|
31 | (2) |
|
|
|
33 | (1) |
|
1.5 Neuropathology in the clinics: magnetic resonance imaging (MRI) |
|
|
33 | (5) |
|
|
|
33 | (1) |
|
1.5.2 Principles of interpretation |
|
|
34 | (2) |
|
|
|
36 | (1) |
|
|
|
36 | (1) |
|
Neurology/functional neuroanatomy |
|
|
36 | (1) |
|
|
|
37 | (1) |
|
Techniques for PNS and muscle |
|
|
37 | (1) |
|
Basic tissue reaction patterns |
|
|
37 | (1) |
|
|
|
37 | (1) |
|
Artifacts, pseudolesions, old age |
|
|
37 | (1) |
|
Magnetic resonance imaging |
|
|
37 | (1) |
|
|
|
38 | (10) |
|
2.1 Pathophysiology of ischemia |
|
|
38 | (1) |
|
2.2 General strategy for diagnosing vascular lesions |
|
|
38 | (1) |
|
2.3 Common vascular lesions |
|
|
39 | (9) |
|
2.3.1 Vascular lesions of the brain |
|
|
39 | (5) |
|
2.3.2 Vascular lesions of the spinal cord |
|
|
44 | (2) |
|
2.3.3 Ischemia in the peripheral nervous system and muscles |
|
|
46 | (1) |
|
|
|
46 | (1) |
|
|
|
46 | (1) |
|
|
|
46 | (1) |
|
Hypertensive encehalopathy |
|
|
46 | (1) |
|
Fibrocartilagenous emboli |
|
|
47 | (1) |
|
|
|
47 | (1) |
|
|
|
48 | (33) |
|
3.1 Pathophysiology of inflammation |
|
|
48 | (2) |
|
3.1.1 Entry and effect of infectious agents in the nervous system |
|
|
48 | (1) |
|
3.1.2 Immune reaction of the host against the infectious agent in the CNS |
|
|
48 | (1) |
|
3.1.3 Morphological aspects of the immune response |
|
|
49 | (1) |
|
3.2 General strategy for diagnosis of inflammatory lesions |
|
|
50 | (4) |
|
3.2.1 Recognizing major inflammatory reaction patterns |
|
|
51 | (1) |
|
3.2.2 Determining the distribution pattern of the lesions |
|
|
52 | (1) |
|
|
|
52 | (2) |
|
3.3 Common CNS infections |
|
|
54 | (18) |
|
3.3.1 Neurotropic viral infections |
|
|
54 | (4) |
|
3.3.2 Viral granulomatous inflammation |
|
|
58 | (2) |
|
|
|
60 | (1) |
|
3.3.4 Viral leukoencephalitis |
|
|
61 | (2) |
|
3.3.5 Bacterial infections |
|
|
63 | (5) |
|
3.3.6 Mycotic and algal infections |
|
|
68 | (1) |
|
3.3.7 Protozoal infections |
|
|
69 | (1) |
|
3.3.8 Helminth infections |
|
|
70 | (2) |
|
3.4 Non-infectious and immune-mediated inflammatory lesions |
|
|
72 | (9) |
|
|
|
72 | (1) |
|
3.4.2 Neurological diseases assumed to be immune-mediated |
|
|
73 | (6) |
|
|
|
79 | (1) |
|
|
|
79 | (1) |
|
Neurotropic viral infections |
|
|
79 | (1) |
|
Viral granulomatous infections |
|
|
79 | (1) |
|
|
|
79 | (1) |
|
Demyelinating viral infections |
|
|
79 | (1) |
|
|
|
79 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
Non-infectious and Immune-mediated inflammatory disorders |
|
|
80 | (1) |
|
|
|
81 | (11) |
|
4.1 Pathophysiology of CNS trauma |
|
|
81 | (3) |
|
4.1.1 Pathogenesis of brain trauma |
|
|
81 | (1) |
|
4.1.2 Pathogenesis of spinal cord trauma |
|
|
82 | (2) |
|
4.2 General strategy for diagnosis of traumatic CNS lesions |
|
|
84 | (1) |
|
4.3 Traumatic nervous system diseases |
|
|
85 | (7) |
|
4.3.1 Trauma of the brain |
|
|
85 | (2) |
|
4.3.2 Traumatic spinal cord lesions |
|
|
87 | (2) |
|
4.3.3 Trauma in the peripheral nervous system |
|
|
89 | (1) |
|
|
|
90 | (1) |
|
Pathophysiology of CNS trauma |
|
|
90 | (1) |
|
|
|
91 | (1) |
|
Intervertebral disc disease |
|
|
91 | (1) |
|
|
|
91 | (1) |
|
|
|
91 | (1) |
|
Other causes of cord compression |
|
|
91 | (1) |
|
|
|
91 | (1) |
|
5 Congenital malformations |
|
|
92 | (14) |
|
|
|
92 | (1) |
|
5.1.1 Ontogeny of the CNS |
|
|
92 | (1) |
|
|
|
92 | (1) |
|
5.2 General strategy for diagnosing anomalies of the CNS |
|
|
93 | (1) |
|
|
|
93 | (13) |
|
5.3.1 Neural tube closure defects |
|
|
93 | (1) |
|
5.3.2 Defects of forebrain induction |
|
|
94 | (1) |
|
5.3.3 Neuronal migration disorders and sulcation defects |
|
|
95 | (1) |
|
5.3.4 Disorders of proliferation or size |
|
|
96 | (1) |
|
5.3.5 Encephaloclastic defects |
|
|
97 | (1) |
|
5.3.6 Malformations in the caudal fossa and spinal cord |
|
|
97 | (3) |
|
5.3.7 Congenital hydrocephalus and other anomalies of CSF pathways |
|
|
100 | (4) |
|
|
|
104 | (1) |
|
Neural tube closure defects |
|
|
104 | (1) |
|
Defects of forebrain induction |
|
|
104 | (1) |
|
Neuronal migration disorders and sulcation defects |
|
|
104 | (1) |
|
|
|
104 | (1) |
|
|
|
104 | (1) |
|
|
|
104 | (1) |
|
Chiari malformation, Syringomyelia |
|
|
104 | (1) |
|
|
|
104 | (1) |
|
Arachnoidal and ependymal cysts |
|
|
105 | (1) |
|
6 Metabolic-toxic diseases |
|
|
106 | (23) |
|
6.1 General strategy for diagnosis of metabolic-toxic lesions |
|
|
106 | (2) |
|
|
|
106 | (1) |
|
6.1.2 Further differential diagnosis |
|
|
106 | (2) |
|
6.2 Encephalomalacias/myelomalacias |
|
|
108 | (10) |
|
6.2.1 Polioencephalomalacia (PE) or cerebrocortical necrosis (CCN) |
|
|
108 | (6) |
|
6.2.2 Polioencephalomalacia of subcortical structures and brainstem |
|
|
114 | (1) |
|
|
|
115 | (1) |
|
6.2.4 Leukoencephalomalacias |
|
|
116 | (1) |
|
6.2.5 Encephalomalacias involving both gray and white matter |
|
|
117 | (1) |
|
6.3 Acquired metabolic-toxic selective lesions |
|
|
118 | (4) |
|
6.3.1 Neuronal degeneration |
|
|
118 | (3) |
|
6.3.2 Axonal degeneration |
|
|
121 | (1) |
|
6.3.3 Myelin degeneration |
|
|
121 | (1) |
|
|
|
122 | (2) |
|
6.5 Metabolic-toxic lesions of the peripheral nervous system (PNS) and skeletal muscle |
|
|
124 | (5) |
|
6.5.1 Metabolic-toxic neuropathies |
|
|
125 | (1) |
|
6.5.2 Metabolic-toxic myopathies |
|
|
125 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (1) |
|
Polioencephalomalacia large animals |
|
|
126 | (1) |
|
Polioencephalomalacia in small animals |
|
|
126 | (1) |
|
Hippocampal necrosis and sclerosis |
|
|
126 | (1) |
|
Subcortical and brainstem encephalomalacias |
|
|
126 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (1) |
|
|
|
127 | (1) |
|
Metabolic toxic neuronal degenerations |
|
|
127 | (1) |
|
|
|
127 | (1) |
|
Acquired lysosomal storage diseases |
|
|
127 | (1) |
|
Metabolic-toxic axonal degenerations |
|
|
127 | (1) |
|
Irradiated feed-induced myelinopathy in cats |
|
|
127 | (1) |
|
Toxic spongy degenerations |
|
|
127 | (1) |
|
|
|
127 | (1) |
|
Toxic peripheral neuropathies |
|
|
127 | (1) |
|
Metabolic peripheral neuropathies |
|
|
128 | (1) |
|
Matabolic-toxic myopathies |
|
|
128 | (1) |
|
|
|
129 | (28) |
|
7.1 General strategy for diagnosis of neoplastic lesions |
|
|
129 | (4) |
|
7.1.1 Clinic and diagnostic imaging |
|
|
129 | (1) |
|
7.1.2 Interpretation of gross findings |
|
|
129 | (1) |
|
|
|
130 | (3) |
|
|
|
133 | (1) |
|
7.2 Tumors of neuroepithelial origin |
|
|
133 | (12) |
|
|
|
133 | (4) |
|
|
|
137 | (2) |
|
7.2.3 Mixed gliomas (oligoastrocytomas) |
|
|
139 | (1) |
|
|
|
140 | (2) |
|
7.2.5 Choroid plexus tumors (papillomas and carcinomas) |
|
|
142 | (1) |
|
7.2.6 Neuronal and mixed neuronalglial tumors |
|
|
143 | (1) |
|
|
|
144 | (1) |
|
7.3 Tumors of cranial and spinal nerves |
|
|
145 | (2) |
|
|
|
145 | (2) |
|
7.3.2 Malignant peripheral nerve sheath tumors (MPNST) |
|
|
147 | (1) |
|
7.4 Tumors of the meninges |
|
|
147 | (4) |
|
|
|
147 | (3) |
|
7.4.2 Granular cell tumor |
|
|
150 | (1) |
|
|
|
151 | (1) |
|
7.5 Lymphomas and hematopoietic tumors |
|
|
151 | (1) |
|
7.5.1 Primary T and B cell lymphomas |
|
|
151 | (1) |
|
7.5.2 Intravascular lymphoma |
|
|
151 | (1) |
|
7.5.3 Metastatic lymphoma |
|
|
152 | (1) |
|
7.5.4 Primary CNS histiocytic sarcoma |
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
153 | (1) |
|
7.7 Embryonal tumors of non-neuroepithelial origin |
|
|
153 | (1) |
|
7.7.1 Thoracolumbar spinal cord tumor (ectopic nephroblastoma) |
|
|
153 | (1) |
|
7.8 Secondary or metastatic tumors |
|
|
154 | (3) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
Lymphomas and hemapoetic tumors |
|
|
156 | (1) |
|
|
|
156 | (1) |
|
|
|
156 | (1) |
|
|
|
156 | (1) |
|
|
|
157 | (36) |
|
8.1 General strategy for differential diagnosis of degenerative lesions |
|
|
157 | (2) |
|
8.1.1 Recognizing the major patterns |
|
|
157 | (1) |
|
|
|
157 | (2) |
|
|
|
159 | (1) |
|
8.2 Degeneration of neurons |
|
|
159 | (7) |
|
|
|
159 | (1) |
|
8.2.2 Motor neuron diseases |
|
|
159 | (3) |
|
8.2.3 Cerebellar degenerations |
|
|
162 | (3) |
|
8.2.4 Other neuronal degenerations |
|
|
165 | (1) |
|
|
|
166 | (7) |
|
8.3.1 Wallerian-like degenerative axonopathies |
|
|
166 | (5) |
|
8.3.2 Axonopathies with prominent axonal swelling |
|
|
171 | (2) |
|
|
|
173 | (5) |
|
|
|
173 | (4) |
|
|
|
177 | (1) |
|
|
|
178 | (4) |
|
8.5.1 Lysosomal storage diseases |
|
|
178 | (3) |
|
8.5.2 Neuronal ceroid lipofucsinoses (NCL) |
|
|
181 | (1) |
|
|
|
181 | (1) |
|
8.5.4 Acquired lysosomal storage diseases |
|
|
182 | (1) |
|
8.6 Spongiform encephalopathies |
|
|
182 | (3) |
|
8.6.1 Transmissible degenerative diseases |
|
|
182 | (1) |
|
8.6.2 Neuropathology of TSE |
|
|
183 | (1) |
|
8.6.3 TSEs in domestic animals |
|
|
184 | (1) |
|
|
|
185 | (2) |
|
8.7.1 Definition and general morphological features |
|
|
185 | (1) |
|
8.7.2 Spongy degeneration in branched-chain organic acidurias |
|
|
186 | (1) |
|
8.7.3 Spongy degenerations of other causes |
|
|
187 | (1) |
|
8.8 Selective symmetrical encephalomalacias (SSE) |
|
|
187 | (2) |
|
8.8.1 General morphological features |
|
|
187 | (1) |
|
8.8.2 Mitochondrial encephalopathies in people and similar lesions in animals |
|
|
187 | (2) |
|
8.9 Degenerative diseases of the peripheral nervous system and muscle |
|
|
189 | (4) |
|
8.9.1 Degenerative polyneuropathies |
|
|
189 | (1) |
|
8.9.2 Degenerative myopathies |
|
|
189 | (1) |
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
Other neuronal degenerations |
|
|
190 | (1) |
|
|
|
190 | (1) |
|
Wallerian-like axonal degenerations |
|
|
190 | (1) |
|
Degenerative myelopathy in old dogs |
|
|
190 | (1) |
|
Wallerian-like degeneration in large animals |
|
|
191 | (1) |
|
|
|
191 | (1) |
|
|
|
191 | (1) |
|
|
|
191 | (1) |
|
Lysosomal storage diseases |
|
|
191 | (1) |
|
Spongiform encephalopathies |
|
|
191 | (1) |
|
|
|
191 | (1) |
|
Selective symmetrical encephalomalacias |
|
|
192 | (1) |
|
Degenerative diseases of the PNS and muscles |
|
|
192 | (1) |
| Index |
|
193 | |